OPEN END TURBO BULL OPTIONSSCHEIN - AMGEN | Market Closed - Bid/Ask 03:42:06 2024-06-26 pm EDT | After market 03:59:47 pm | |||
| 8.8 EUR | -5.98% |
|
8.735 | -0.74% |
| Current month | +17.44% | ||
| 1 month | +15.13% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 8.8 | -5.98% |
| 24-06-25 | 9.36 | +3.08% |
| 24-06-24 | 9.08 | +6.70% |
| 24-06-21 | 8.51 | +1.19% |
| 24-06-20 | 8.41 | +3.83% |
Real-time BOERSE MUENCHEN
Last update June 26, 2024 at 03:42 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC3NQT |
| ISIN | DE000HC3NQT1 |
| Date issued | 2023-01-30 |
| Strike | 219.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.55 € |
|---|---|
| Lowest since issue | 1.03 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
